305 related articles for article (PubMed ID: 24786631)
1. Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease.
Berchtold NC; Sabbagh MN; Beach TG; Kim RC; Cribbs DH; Cotman CW
Neurobiol Aging; 2014 Sep; 35(9):1961-72. PubMed ID: 24786631
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal gene expression patterns linked to late-life physical activity oppose age and AD-related transcriptional decline.
Berchtold NC; Prieto GA; Phelan M; Gillen DL; Baldi P; Bennett DA; Buchman AS; Cotman CW
Neurobiol Aging; 2019 Jun; 78():142-154. PubMed ID: 30927700
[TBL] [Abstract][Full Text] [Related]
3. Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer disease.
Han P; Caselli RJ; Baxter L; Serrano G; Yin J; Beach TG; Reiman EM; Shi J
JAMA Neurol; 2015 Mar; 72(3):333-9. PubMed ID: 25599520
[TBL] [Abstract][Full Text] [Related]
4. Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment.
Counts SE; Alldred MJ; Che S; Ginsberg SD; Mufson EJ
Neuropharmacology; 2014 Apr; 79():172-9. PubMed ID: 24445080
[TBL] [Abstract][Full Text] [Related]
5. Correlation of Presynaptic and Postsynaptic Proteins with Pathology in Alzheimer's Disease.
Serrano GE; Walker J; Nelson C; Glass M; Arce R; Intorcia A; Cline MP; Nabaty N; Acuña A; Huppert Steed A; Sue LI; Belden C; Choudhury P; Reiman E; Atri A; Beach TG
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542104
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
[TBL] [Abstract][Full Text] [Related]
7. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
[TBL] [Abstract][Full Text] [Related]
8. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
[TBL] [Abstract][Full Text] [Related]
9. Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease.
Scheff SW; Price DA; Ansari MA; Roberts KN; Schmitt FA; Ikonomovic MD; Mufson EJ
J Alzheimers Dis; 2015; 43(3):1073-90. PubMed ID: 25147118
[TBL] [Abstract][Full Text] [Related]
10. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain
Mitolo M; Stanzani-Maserati M; Capellari S; Testa C; Rucci P; Poda R; Oppi F; Gallassi R; Sambati L; Rizzo G; Parchi P; Evangelisti S; Talozzi L; Tonon C; Lodi R; Liguori R
Neuroimage Clin; 2019; 23():101843. PubMed ID: 31071594
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
[TBL] [Abstract][Full Text] [Related]
12. Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease.
Berchtold NC; Coleman PD; Cribbs DH; Rogers J; Gillen DL; Cotman CW
Neurobiol Aging; 2013 Jun; 34(6):1653-61. PubMed ID: 23273601
[TBL] [Abstract][Full Text] [Related]
13. Impacts of CD33 Genetic Variations on the Atrophy Rates of Hippocampus and Parahippocampal Gyrus in Normal Aging and Mild Cognitive Impairment.
Wang WY; Liu Y; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Tan L; Yu JT;
Mol Neurobiol; 2017 Mar; 54(2):1111-1118. PubMed ID: 26803496
[TBL] [Abstract][Full Text] [Related]
14. Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study.
Cribbs DH; Berchtold NC; Perreau V; Coleman PD; Rogers J; Tenner AJ; Cotman CW
J Neuroinflammation; 2012 Jul; 9():179. PubMed ID: 22824372
[TBL] [Abstract][Full Text] [Related]
15. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
[TBL] [Abstract][Full Text] [Related]
17. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
18. Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease.
Baazaoui N; Flory M; Iqbal K
J Alzheimers Dis; 2017; 56(4):1385-1401. PubMed ID: 28222506
[TBL] [Abstract][Full Text] [Related]
19. Altered amplitude of low-frequency fluctuations in early and late mild cognitive impairment and Alzheimer's disease.
Liang P; Xiang J; Liang H; Qi Z; Li K; Alzheimer's Disease NeuroImaging Initiative
Curr Alzheimer Res; 2014 May; 11(4):389-98. PubMed ID: 24720892
[TBL] [Abstract][Full Text] [Related]
20. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
